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Topic 02 – Heart failure and cardiomyopathy 
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Background: Tako-Tsubo cardiomyopathy is a stress-induced cardiomyo-
pathy and is characterized by transient left ventricular (LV) systolic dysfunction.
During the hospitalization, recovery may rapidly occur with a partial increase of
LV ejection fraction. The aim of this prospective study was to assess LV sys-
tolic dysfunction in a large population of Tako-Tsubo cardiomyopathy.
Methods: The study population included 90 patients presenting with Tako-
Tsubo cardiomyopathy (85 women, 71±12 y.o.). This is a substudy of the mul-
ticentric prospective TAKO-GENE study (ClinicalTrials.gov Identifier:
NCT01520610). TTC was defined according to the Mayo-Clinic criteria and
LV systolic function was assessed by multimodality imaging.
Results: Among Tako-Tsubo cardiomyopathy, a typical pattern was
observed in 73 pts, an apical-sparing variant in 16 pts and an inverted Tako-
Tsubo cardiomyopathy in 1 patient. Mean LV ejection fraction assessed by
echocardiography was 39.3±11.4% and was significantly lower than LV ejec-
tion fraction calculated by LV angiography (43.1±12.7%, p<0.05) and by car-
diac magnetic resonance (49.6±11.8%, p<0.0001). Assessment of LV ejection
fraction was performed by echocardiography at admission, by LV angio-
graphy between day 0 and day 3 and by cardiac magnetic resonance between
day 2 and day 7.
Conclusion: Echocardiography allows a fast and immediate assessment of
LV ejection fraction whereas assessment of LV systolic dysfunction may be
delayed by LV angiography and cardiac magnetic resonance.
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Background: Cardiac diseases are associated with a high prevalence of
sleep apnoea syndrome (SAS) particularly in heart failure. Two types of SAS
are known: central or obstructive. Heart failure can occur in patients with pri-
mary systemic amyloidosis (AL), senile systemic amyloidosis (SSA), and
Transthyretin-Related Amyloidosis (TTR). There is no data about prevalence
and severity of sleep disordered breathing in cardiac amyloidosis.
Aims: Assess the prevalence and severity of SAS in cardiac amyloidosis.
Methods: Patients prospectively referred in our cardiology department for
cardiac amyloidosis underwent polygraphy to diagnose sleep apnoea
syndrome (SAS) between 2010 and 2012. SAS was deﬁned as an apnoea-
hypopnoea index greater or equal to 5 events/h.
Results: Thirty five patients were included, of whom 15 had AL, 9 FAP
and 11 SSA. Mean age, body mass index, NTproBNP, and left ventricular
ejection fraction, of the overall cohort were respectively 72±12 years, 24±4kg/m²,
5642±7812 and 48±13% and. The prevalence of SAS was 86%. 29% of syn-
dromes were classiﬁed as central and 57% as obstructive. The mean apnoea
hypopnoea index was 22±14 events/h and was superior to 30 events/h in
11 patients. SSA were significantly older but NTproBNP and LVEF were not
different between the three type of amyloidosis. Apnoea hypopnoea index was
more elevated in SSA and FAP than in AL (p=0.01). 
Conclusion: The prevalence of sleep-disordered breathing is high in car-
diac amyloidosis population, with most syndromes having an obstructive pat-
tern. Effect of SAS treatment should be investigated in this population.
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Background: Despite the association of symptoms with LV outflow tract
obstruction in HCM, there exist paradoxical situations in which significant
intraventricular gradients (>50 mmHg) at rest occur in conjunction with excel-
lent exercise tolerance. 
Objectives: To analyze left ventricular (LV) obstruction in hypertrophic
cardiomyopathy (HCM) during exercise echocardiography.
Methods: To examine this phenomenon we performed exercise echo-
cardiography and analyzed the clinical status in 107 HCM patients with and
without resting obstruction.  
Results: At rest, 69 patients had no obstruction while 38 exhibited an intra-
ventricular gradient,  9 of whom exhibited a decrease in gradient of at least
30 mmHg (99+35 to 30+14 mmHg, p<0.001) during exercise (paradoxical
response to exercise or PRE). PRE patients presented a significantly lower
NYHA clinical class and higher left ventricular volumes and arterial pressure
both at rest and during exercise than HCM patients for whom the gradient
increased or did not change during stress echocardiography. Finally, PRE
patients exhibited a trend toward a reduced rate of cardiac events.
Conclusions: Our study identified a new subgroup of HCM patients, des-
ignated PRE, based on a decreased intraventricular gradient during exercise.
The reduced exertional obstruction may account for the better functional class
and trend to less clinical events in PRE patients.
059
Genotype/phenotype analysis and pathophysiology of desmoglein-2
propeptide cleavage-site mutations in arrhythmogenic right ventricu-
lar cardiomyopathy
Alexia Vite (1), Estelle Gandjbakhch (2), Véronique Fressard (3), Guillaume
Duthoit (2), Erwan Donal (4), Etienne Delacretaz (5), Géraldine Bertaux (6),
Françoise Hidden-Lucet (2), Philippe Charron (2), Eric Villard (1)
(1) Inserm UMRS 956, Paris, France – (2) Hôpital La Pitié-Salpêtrière,
Cardiologie, Paris, France – (3) Hôpital La Pitié-Salpêtrière, Service de
Biochimie (Unité de Cardiogénétique et Myogénétique), Paris, France –
(4) CHU Rennes – Hôpital Pontchailloux, Cardiologie, Rennes, France –
(5) Hôpital de l'Ile, Service de Cardiologie, Berne, Suisse – (6) CHU
Dijon, Service de Cardiologie, Dijon, France
January 16th, Thursday 2014
© Elsevier Masson SAS. All rights reserved.
 
Archives of Cardiovascular Diseases Supplements (2014) 6, 20-34 21
Background: Desmoglein-2 (DSG2) mutations are common causes of
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC). A hot spot of
missense mutations targets the consensus cleavage-site of DSG2 pro-peptide
(Arg-X-Arg/Lys-Arg) by Kex2-like proprotein-convertases (PCs). We identi-
fied heterozygous missense DSG2 mutations of the cleavage site (p.R46W,
p.R46Q, p.R49H and p.K48N) in ten probands out of 200 independant ARVC
probands and seven additional relatives. This study analyses the phenotype
associated to these specific mutations and experimentally explores their
molecular consequences.
Methods and Results: The pro-DSG2 cleavage site mutations were asso-
ciated with a severe phenotype with diffuse RV dilatation, severe RV dysfunc-
tion and frequent LV involvement leading to end-stage heart failure in 3 out
of 17 mutation-carriers. Through ex vivo and in vitro analysis by expressing a
WT or mutant DSG2-GFP fusion protein in cellular models, we demonstrated
that all mutations prevented efficient propeptide cleavage. However mutants
pro-DSG2 were correctly addressed to the intercellular junctions. We demon-
strated that the presence of propeptide led to the abolition of interactions
between the N-ter EC1 domains of the cadherins.This was accompanied with
a mis-incorporation of pro-DSG2 into desmosomes as revealed by iF labelling
at low Ca2+ concentrations compared to WT DSG2, due to an EGFR-depen-
dant internalization of mutant pro-DSG2 and of its partners PKP2 and PG.
Finally, we observed by WB an increase in the soluble pool of mutant pro-
DSG2 compared to the WT DSG2  when cells were submitted to mechanical
stress.
Conclusion: DSG2 propeptide cleavage-site mutations are associated with
a severe phenotype and an increased risk of heart failure. Our experimental
results indicated a loss of DSG2 adhesiveness properties and a decrease of the
incorporation of mutant DSG2 into desmosomes due to propeptide cleavage
abolition that could play an important role in ARVC pathophysiology. 
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Introduction: According to the ESC Working Group on Myocardial and
Pericardial Disease, left ventricular non compaction (LVNC) is still an unclas-
sified cardiomyopathy. Although LVNC is associated with a high incidence of
morbidity and mortality, reports about prognosis are contradictory. So we
sought to assess the incidence and the predictors of major complications and
myocardial contractile recovery.
Methods: This retrospective study enrolled 32 patients who fulfilled the
diagnostic criteria of LVNC.Clinical data, cardiac echography and MRI data-
base of our institution was searched for all these patients. Follow-up included
an interval history, a focused physical examination and a transthoracic echo-
cardiogram.
Results: The mean age at diagnosis was 48.3±16.4 years. The most fre-
quent symptom at diagnosis was dyspnea NYHA class III/IV (43%). The
mean LV end-diastolic diameter was 66.4 mm and the mean EF was 29.5%.
Duration of follow-up was 480 days. Major complications were heart failure
in 13 patients (40%), thromboembolic events in 3 patients (9%) and ventric-
ular tachycardia in 1 patient (3%). There were no unregistered deaths. There
was no predictive role for any variable to specific complications. A worse
NYHA class, a lower baseline LVEF, LV dimensions, wall thickness and E/é
ratio did not predict MACE. During the follow-up 4 patients (12%) showed
myocardial contractile recovery and 9 patients (28%) showed an improve-
ment, with a increase in the mean LVEF to 38.5% (p<0.001). LV systolic
improvement was inversely associated with the presence of a left bundle
branch block (p=0.071) and LV end-diastolic volume (p=0.052).
Conclusion: Our study demonstrates a high incidence of complications in
LVNC disease. However, a relatively large number of patients may show a
significant improvement in the LV systolic function shortly after the onset of
symptoms. The improvement is unlikely to occur in patients with left bundle
branch block and dilated LV. 
061
Usefulness of right ventricle 2D strain in arrythmogenic right ven-
tricle dysplasia/cardiomyopathy
Aude Healy-Brucker (1), Françoise Pousset (1), Sandrine Almeida (1), Estelle
Gandjbakhch (2), Guillaume Duthoit (2), Jean-Louis Hébert (3), Lila Bou-
brit (1), Nadjib Hammoudi (1), Richard Isnard (1), Françoise Hidden-Lucet (2)
(1) Hôpital La Pitié-Salpêtrière, Cardiologie, Paris, France – (2) Hôpital
La Pitié-Salpétrière, Département de Cardiologie-Unité de Rythmologie,
Paris, France – (3) Hôpital Pitié-Salpêtrière, Paris, France
Background: Diagnosis of Arrhythmogenic Right Ventricular (RV) Dys-
plasia/Cardiomyopathy (ARVD/C) is based on International Task Force Cri-
teria (ITFC). But the diagnosis remains challenging especially in the early
course of the disease.The purpose of this study was to assess if the RV 2D
strain analysis could be an accurate tool to detect RV abnormalities in patient
with suspicion of ARVD/C. 
Methods: We enrolled 95 patients with suspicion of ARVD/C referred to
our institution. ECG, SAECG, echocardiography and RV angiography were
performed in all patients. Based on ITFC and a final experts’agreement, the
patients were classified as follows: affected ARVD/C (n=50), borderline
ARVD/C (n=9) or normal (n=36). In addition, RV longitudinal strain was
measured in 6 RV segments obtained from the RV focused apical 4-chamber
view. Analysis was performed offline and blinded of the final diagnosis.
Results: Compared to normal, affected patients had only a mild decrease
in RV fractional area change (FAC)(37±9% vs 44±7% p=0.0002) and an mild
increase RV outflow tract diameter (RVOT)(35±6mm vs 32±5mm, p=0.002).
Borderline had normal FAC and increase RVOT. Affected patients displayed
a reduced global RV strain (RV-GS)(-20.8± 4.8% vs-24.8±3.3% p<0.0001).
Segmental strain analysis showed the reduction was major in the lateral-basal
segment (RV-LBasS), the lateral-mid segment (RV-LMidS) and the septum-
basal segment (RV-SBasS). Bordeline’s patients had no significant altered RV
strain compared to normals or affected patients. 
Conclusion: RV 2D strain is significantly lower in affected ARVD/C
patients compared with normal normal, but not with borderline, especially in
mid lateral and basals segments. The presence of a RV strain impairment may
be useful for the diagnosis of ARVD/C in the early course of the disease.
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Objective: To estimate the prevalence and incidence of congestive heart
failure (CHF) in populations with and without type 2 diabetes and to identify
risk factors for diabetes-associated CHF.
Research design and methods: We searched the inpatient and outpatient
electronic medical records of 324 individuals diagnosed with type 2 diabetes
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before 1 January 2011and those of an age- and sex-matched control group
without diabetes for a diagnosis of CHF. Among those without a baseline
diagnosis of CHF, we searched forward for 24 months for incident cases of
CHF. We constructed multiple logistic regression models to identify risk fac-
tors for both prevalent and incident CHF.
Results: CHF was prevalent in 11.8% (n=1,131) of diabetic subjects and 4.5%
(n=72) of control subjects at baseline. We observed incident cases of CHF in 7.7%
of diabetic subjects free of CHF and in 3.4% of control subjects. In diabetic sub-
jects, age, diabetes duration, insulin use, ischemic heart disease, and elevated
serum creatinine were independent risk factors for both prevalent and incident
CHF. Better glycemic control at baseline, and improved glycemic and blood pres-
sure control at follow-up predicted the development of CHF. In addition, the renal
function was deteriorate in the diabetic group,related to the risk of CHF.
Conclusions: Despite controlling for age, duration of diabetes, presence of
ischemic heart disease, and presence of hypertension, insulin use was associated
with both prevalent and incident CHF. Why insulin use and better glycemic con-
trol both at baseline and follow-up independently predicted CHF deserves further
study.
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What are particularities in echocardiography and doppler of diabetics
with chronic heart failure?
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CHU Ibn Rochd Casablanca, Cardiologie, Casablanca, Maroc
Introduction: The prevalence of heart failure and diabetes are both
increasing: 25 to 30% of patients with heart  failure suffer from diabetes.
Diabetics have more diastolic dysfunction because accumulation collagen
in intramyocardial.
The objectives of our study are to compare echocardiographics and Dop-
pler profiles of diabetics  and non diabetics.
Material and methods: We included 1800 patients, diabetics and non dia-
betics, admitted in united of heart failure in our Center of Cardiology from
May 2009 to October 2012. All patients were evaluated by echocardiography
and Doppler .
The data are presented as numbers, percentages, and medians with inter-
quartile range. the distribution of variables was compared between diabetics
and non diabetics by chi-square test with confidence intervals.
Results: similarity of the parameters studied between the 2 groups dia-
betics and non diabetics in terms of morphology and hemodynamics ( end dia-
stolic left ventricle volume; mitral regurgitation; interventricular septum size;
pulmonary arterial systolic pressure; left atrial volume …. ). But, we have
found important differences of 3 parameters: Ejection fraction of left ventricle
was higher (48, 5% and 35% ) in diabetics group. We found more segmental
kinetic disorders (76% and 50%) and more diastolic dysfunction with higher
filling pressures  (51% and 34%) in diabetic population.
Conclusions: So, in our study, we have found more diastolic dysfunction
and more segmental kinetic disorders but ejection fraction of left ventricle is
higher in patients diabetics with chronic heart failure. In General, our results
were consistent with most of the European and American registers
These findings emphasize the importance of individualised management
and need for more comprehensive recruitment of diabetics in clinical trials.
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Introduction: Prognostic value of increased pulmonary pressure and its
link to haemolysis are well established in homozygous sickle cell disease
(HSC). Left ventricular (LV) remodelling has been less studied in these
patients, and is attributed solely to anaemia. 
Objectives: Study the determining factors of LV remodelling in HSC and
investigate its relation to pulmonary pressure.
Methods: 154 stable HSC patients (28.6±8.5 years, 99 women) and a
control group of 45 age and sex-matched people underwent echocardiography.
LV end-diastolic volume was measured by Simpson method and indexed to
body surface area (LVVi); cardiac index (CI), LV filling pressure (E/e’) and
pulmonary pressure by tricuspid regurgitation (TR) were also measured.
Clinical and biological data were collected. 
Results: LVVi, CI, E/e’ and TR were significantly increased in HSC
patients compared to the control group (table). Multivariate analysis in the
patient group showed that the two determining factors of LVVi are haemo-
globin (anaemia) and bilirubin (chronic haemolysis).
TR is determined by age, CI and E/e’.
Conclusion: In homozygous sickle cell disease, the LV is dramatically
dilated. Haemolysis along with anaemia is one of the LV remodelling deter-
mining factors in these patients.
Pulmonary pressure seems well linked to left heart modification.
Table
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Prevalence of anaemia in heart failure to the university hospital of
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Objectives: to determine the prevalence of anaemia in heart failure, and to
evaluate its impact on the pronostic.
Patients and methods: it was about a cross-sectional study with prospective
collection, carried out of the january 1st at december 31th, 2010 in the service of
cardiology and internal medicine of the university hospital of Brazzaville. This
study included patients admitted for a left or global heart failure. Anaemia was
defined by a rate of haemoglobin<12 g/dl at the man and <11 g/dl at the woman.
Two hundred and seventy two patients were retained, divided into two groups
according to anaemic patients (n=114) and non anaemic patients (n=158).
Results: they were 130 men (47.8%) and 142 women (52.2%), old on
average of 56.9±16.5 years (extreme: 18 and 97 years). The prevalence of
anaemia was 42%, with an average rate of haemoglobin of 11.9±4.4 g/dl
(extreme: 4.7 and 15.2 g/dl). The subjacent heart diseases were a hypertensive
heart disease in 106 cases (39.0%), a dilated cardiomyopathy in 86 cases
(31.6%), a myocardit in 27 cases (9.9%), a valvulopathy in 24 cases (8.8%),
an ischaemic heart disease in 15 cases (5.5%), and of unspecified cause in
14 cases (5.1%). Heart failure was global in 233 cases (85.7%) and left in
39 cases (14.3%). Two hundred and forty-nine patients (91.5%) were in func-
tional class III-IV of the NYHA, without difference between the A and NA
(p=0.6). Left ventricle ejection  fraction was 48±14.6% in A and 52.3±14.9%
in NA (p=0.43). Forty seven patients (17.3%) were under anti-vitamin K and
15 (5.5%) under acetylsalisilyc acid. The average duration of stay was of
19.1±16.7 days, without difference between the A and NA (19.4±12 days
Patients
(N=154)
Controls
(N=45)
p
Age (years) 28,6±8,2 29,2±8,2 0,69
Women, n (%) 99 (64) 29 (26) 0,66
CI (L/mn/m²) 4,1±0,9 3,0±0,5 <0,0001
LVVi (ml/m²) 91,9±19,8 54,3±10,8 <0,0001
E/e’ 6,0±1,7 4,6±1,2 <0,0001
TR (m/s) 2,5±0,3 2,2±0,2 <0,0001
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versus 18.8±13.8 days; p=0.79). Mortality rate total was 17%, with a signifi-
cant difference between the A and NA (26% versus 10%; p=0.001).
Conclusion: this preliminary study showed a high prevalence of anaemia
in heart failure, and its negative influence on the pronostic. The assumption of
responsibility for this co-morbidity would make it possible to improve the pro-
nostic of the heart failure patients.
Keywords: heart failure, anaemia, pronostic, Congo.
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Background: In sickle cell disease (SCD), relationship between cardiac
remodeling, cardiac index(CI) and haemoglobin (Hb), red blood cell count
(RBC) and foetal hb (HbF) have not been well characterized.
Methods: We interrogated our hospital database including 1780 SCD
patients. Inclusion criteria were: patients with SS or ST° sickle cell disease
having an echocardiography and without pregnancy. 656 SS-ST° were
included in the analysis with a mean age of 31(25; 40). SCD patients were
compared with 25 age-matched black healthy subjects. Echocardiography
included M-mode, 2D, pulsed Doppler and LV tissue Doppler.
Results: Compared to control, SCD had significant higher left ventricular
diastolic diameter indexed to body surface area (LVEDDind), left atria diam-
eter indexed (LADind), CI, and lower LVEF. Systolic pulmonary artery pres-
sure (sPAP) was not different between the two last groups.
In SCD, LVEF was not correlated with Hb (p=0.74) whereas CI and
LVEDDind were (both R:0.25, p<0.0001). Systolic dysfunction (LVEF<50%)
was observed in only 3.4%
There was poor relationship between LVEDD and CI (R=0.15, p=0.01).
Patients were divided in quartiles of CI and LVEDDind. Patients in the fourth
quartiles (Q4) of LVEDDind (median/range: 35 (34; 37)) and of CI (4.7 (4.5;
5.3)) versus the three others quartiles (Q1-3) had significantly lower Hb, HbF
and RCB and higher lactate dehydrognease and bilirubin which are associated
with hemolysis. 
Patients in Q4 LVEDDind had lower heart rate, LVEF and higher CI,
LADind, sPAP, severity of mitral regurgitation, compared to Q1-3. Patients in
Q4 CI had higher heart rate, LVEDDind, LADind, sPAP, and lower E/A
compared to Q1-3. 
Determinants of Q4 LVEDDind and CI using multivariate binomial regres-
sion analysis were respectively lower Hb and HbF and lower RBC and HbF.
Patients with alpha-thalassemic one or two gene deletions had fewer anemia
and significant lower cardiac remodeling CI.
Conclusion: In SCD, cardiac remodeling and elevated cardiac output are
determined by hematologic variables and associated with hemolytic pattern. 
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Objectives: The present the main clinical aspects and diagnostic problems
of cardiac involvement induced by human immunodeficiency virus infection
(HIV infection/AIDS) in children.
Methods: Patients: 51 children, 2 -16 years old, with HIV infection/AIDS
in various stages of evolution, with diverse symptoms affecting many organs.
Evaluation of patients:clinical, ECG, Chest X ray, echocardiography (echo).
Staging of HIV infection / AIDS by clinical exam and CD4 lymphocytes
values.
Results: 60% of patients were included in group P2f clinical staging. Signs
of cardiac involvement: heart failure (11 cases), tachycardia (20 cases), deaf-
ness of the heart sounds ± gallop rhythm ± systolic murmur of mitral regurgi-
tation (12 cases), dyspneea (14 cases), other non-symptomatic (14 cases) or
with signs of others diseases. ECG: disturbances of ventricular repolarisation,
sinusal tachycardia. Rx.CT: cardiomegaly (30% cases) ± aspects of pulmo-
naryinfections. Echo exam: cardiac involvement in 66% cases: dilated cardio-
myopathy, the most severe changes (14 cases), pericarditis(10 cases), isolated
dilation of the left and right ventricle (6 cases), LV diastolic dysfunctional
(14), pulmonary hypertension (6). The severity and incidence of cardiac dis-
ease was associated with significant reduction of CD4 value <400/mmc. Hys-
tological exam erformed in 28 patients died by pulmonary infections: aspects
of myocarditis, pericardial and myocardial inflammatory infiltration, necrotic
lesions. 
Conclusion: By the high incidence (66% of cases) and severity of clin-
ical manifestations, cardiac suffering during HIV infection / AIDS is one of
the most important problems of these patients.Cardiological evaluation of
patients is necessary in all the stages of the infection, even non-symptom-
atic, for the diagnosis and follow-up of evolution. Echocardiography is the
most sensitive noninvasive method useful for highlighting cardiac damage in
these patients.
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When heart failure has to do with past abdominal surgery…
Julien Plessis, Laurianne Le Gloan, Jean-Noël Trochu, Jean-Pierre Gueffet
CHU Nantes, Cardiologie, Nantes, France
We report the interesting case of a 70-year-old woman admitted to hospital
for progressive dyspnea revealing congestive heart failure.  Her past medical
history was marked by permanent atrial fibrillation, obesity (body mass index
45 kg/m²) and cholecystectomy for symptomatic gallstone.  The first echocar-
diographic evaluation showed preserved left ventricular systolic function, but
a major dilation of right-sided cavities and inferior vena cava. Systolic pulmo-
nary artery pressures were elevated at  60 mm Hg. After a rapid and major
relief of congestive symptoms thanks to high doses of diuretics, a right heart
catheterization was performed and confirmed elevated right-sided pressures
(mPAP: 28 mmHg, PCWP 12 mm Hg) with high cardiac output (5.2l/min/m²).
To explore this patient with congestive heart failure and high cardiac output,
thyroid function and hemoglobin returned in normal ranges. A chest, abdomen
and pelvis computed tomography was performed and demonstrated a large
porto-systemic shunt. A mesenteric angiography was subsequently perfomed
and confirmed the communication between the right side of the portal vein
and the right sub-hepatic vein. The porto-systemic shunt was embolized with
an  amplatzer plugs. As a result of the suppression of the shunt, six months
later, the patient had not experienced any other episodes of congestive heart
failure and echocardiography confirmed the regression of pulmonary hyper-
tension and right-sided cavities enlargement. Extrahepatic portosystemic
venous shunting in the absence of portal hypertension or abdominal trauma is
extremely rare. For our patient, the porto-systemic shunt was probably to attri-
bute to the past cholecystectomy.
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Echocardiographic evaluation of sudden death risk of the arrhythmo-
genic right ventricular cardiomyopathy /dysplasia 
Nora Nabila Ali-Tatar Chentir, Feriel Djender, Mohand Tayeb Chentir
CHU Mustaph, Cardiologie A1, Alger, Algérie
Objective: To describe the clinical, electrocardiographic and echocar-
diographic variables involved in the stratification of the risk of sudden
death of the arrhythmogenic right ventricular cardiomyopathy/dysplasia
(ARVC/D).
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Method: From 2005 to 2012, 25 patients, 22 males and 3 females, mean
age 35.4±16 years range 15-62 years, fulfilling the 2010 ARVCD ESC criteria
were screened. Conventional transthoracic echocardiography and tissue Dop-
pler Imaging (DTI) at the lateral tricuspid annulus were performed to assess
the right and left ventricular cavity size and function among the usual para-
meters.
Results: 
– 1 patients have 2 major criteria: an aspect of major arrhythmia, ventri-
cular tachycardia, and dilated right cavities.
– 7 patients have three major criteria: appearance of ventricular tachy-
cardia, a major anomaly called depolarization wave epsilon and dilated right
cavities. Among them, two patients died ,suddenly in one case and after a
stroke in the other case where echography showed very dilated right cavities
with very dense spontaneous contrast. 
– 4 Patients diagnosed with 4 major criteria: the occurrence of syncope,
epsilon wave, ventricular tachycardia and dilated right cavities.
– 3 patients with a family history of sudden death and dilated right cavities.
– Ventricular function was decreased in 11 patients.
Discussion and Conclusion: Echocardiography takes an important
place in the diagnosis and prognostic of ARVD and allows to screen non
invasively all the members of the family when the diagnosis has been
made.
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The contribution of echocardiographic parameters of cardiac dys-
synchrony in the prognosis of heart failure: about 61 cases 
Sana Sioua, Sana Fennira, Saoussen Antit, Mohamed Habib Khaldi,
Sondes Kraiem
Hôpital Habib Thameur, Cardiologie, Tunis, Tunisie
Introduction: The evaluation of the prognosis of heart failure secondary to
dilated cardiomyopathy is an important step for the identification of patients
with high cardiac risk events requiring aggressive therapy.
Materials and results: We conducted a prospective study on 61 patients
with heart failure secondary to dilated cardiomyopathy stabilized with medical
therapy. We studied the relationship between the different echocardiographic
parameters of dyssynchrony and the occurrence of secondary cardiac events
like death, decompensated heart failure and ventricular tachycardia. During
the follow-up (11±5 months) 5 patients died, 22 patients were hospitalized for
decompensated heart failure and 2 patients had untolerated ventricular tachy-
cardia. A total of 25 patients have at least a cardiac event. Concerning mor-
tality, the atrioventricular and intraventricular dyssynchrony was more
frequent for the patients who died than for those who survived without a sta-
tistically significant difference. On the contrary, the interventricular asyn-
chrony was inversely related to the hospitalization for decompensated heart
failure. Concerning the occurrence of an overall cardiac event, the absence of
an interventricular asynchrony was a predictive factor (p=0.003) with a risk
multiplied by 6. The intraventricular dyssynchrony was more frequent for
patients who presented a cardiac event (56% vs. 47%).
Conclusion: We conclude that the assessment of dyssynchrony would be
efficient for the evaluation of the prognosis of heart failure secondary to
dilated cardiomyopathy. Nonetheless, studies at larger scales are useful first,
to better support the evaluation of the cardiac dyssynchrony and second, to
guide the therapeutic management.
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The interrelation between diastolic dysfunction and interleukin-1β
level in patients with diabetic cardiomyopathy
Larysa Zhuravlyova, Nelya Sokolnikova
Kharkiv National medical university, internal medicine N3, Kharkiv,
Ukraine
The formation of diabetic cardiomyopathy (DCMP) against the background
of diabetes mellitus type 2 (DM-2) is associated not only with insulin resis-
tance, hyperinsulinemia and glucose toxicity, but also with the activation of
proinflammatory cytokins. One of the mediators of inflammation is inter-
leukin-1β (IL-1β), which is the marker of severity and the predictor of the
development of cardiovascular diseases. However, the extent of IL-1β
involvement into the development of diastolic dysfunction (DD), typical for
metabolic cardiomyopathy, is not well studied. 
The purpose of our research was to evaluate the interconnection between
the DD and the level of IL-1β in patients with DM-2. 
Methods: 64 patients (35-60 years old) with DM-2 of moderate severity
without signs of coronary artery disease, hypertension and heart failure were
examined. Duration of DM-2 was from 1 to 8 years. The level of IL-1β (pg/mL)
was determined by immune-enzyme assay. The maximal velocity of early dia-
stolic stream E; stream velocity, caused by atrial systoles A; and an E/A ratio
were measured by heart sonography. Control group included 20 relatively
healthy individuals. 
Results: The mean level of E/A composed 0.82±0.022 in the group of
patients with DM-2 and 1.4±0.075 (p<0.05) in the control group. The mean
level of IL-1β counted 14.76±0.28 (p<0.05) in group of patients with DM-2
and 8.12±0.24 in the control group. A significant reliable correlation was
revealed between E/A ratio and IL-1β level (R -0.27 (p<0.05)).
Conclusion: The received data prove that proinflammatory IL-1β contri-
butes into the formation of DCMP and favors the development of diastolic
dysfunction, followed by formation of heart failure in patients with DM-2.Figure – ARVD. Intra right ventricular thrombus
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Causes of readmission for heart failure to the university hospital of
Brazzaville.
Méo Stéphane Ikama, Bernice Nsitou, Solange Mongo Ngamani, Gisèle
Kimbally-Kaky, Jean Louis Nkoua
CHU Brazzaville, Cardiologie, Brazzaville, Congo
Objectives: to identify the independent factors of decompensation of heart
failure, and to propose axes of prevention.
Patients and methods: it was about a cross-sectional study with prospec-
tive collection, descriptive, carried out of the january 1st at december 31th,
2010 in the service of cardiology of the university hospital of Brazzaville.
This study included known patients and treaties for heart failure, readmitted in
the service for a push of left or global heart failure. Hundred twenty-five
patients were retained, divided into 69 men (55.2%) and 56 women (44.8%).
Results: The median age of the patients was 59±14 years (extreme: 32 and
97 years), and the sex-ratio 1.2. The patients were of a standard of living
raised in 39 cases (31.2%), weak in 47 cases (37.6%), and without income in
39 cases (31.2%). The principal subjacent heart diseases were a hypertensive
heart disease in 40 cases (32.0%), a dilated cardiomyopathy in 36 cases
(28.8%), a valvulopathy in 21 cases (16.8%), and an ischaemic heart disease
in 14 cases (11.2%). The maintenance treatment comprised diuretic in
95 cases (76.0%), an ACE/ARA2 in 88 cases (70.4%), digoxin in 31 cases
(24.8%), spironolactone in 29 cases (23.2%), a beta-blocker in 12 cases
(9.6%). Twenty-five patients (20%) were under acetylsalisylic acid and 24
(19.2%) under anti-vitamin K. The identified independent factors of decom-
pensation were a variation of mode in 84 cases (67.2%), an interruption of
maintenance treatment in 83 cases (66.4%), a pulmonary embolism supposed
in 46 cases (36.8%), a flu syndrome with bronchopulmonary superinfection in
19 cases (15.2%), and an anaemia in 9 cases (7.2%). The other factors were
represented by a hypertensive push (n=4), a passage in atrial fibrillation
(n=3), and a myocardial ischaemia in one case.
Conclusion: the assumption of responsibility of heart failure remains dif-
ficult in Congo. Its optimization passes by the education of the heart failure
patients, and by the improvement of the living conditions of these often
modest populations.
Keywords: heart failure, readmission, Congo.
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Precipitating factors associated with diastolic heart failure in the
elderly
Naouar Benyassine, Salwa El Karimi, Mostapha El Hattaoui 
CHU Mohamed XI, Cardiologie, Marrakeh, Maroc
Beside basal myocardial dysfunction, acute heart failure involves associ-
ated factors, which increase pulmonary capillary pressure or decrease colloid
osmotic pressure. The aim of this study was to evaluate the prevalence of
these precipitating factors in a population presenting with acute heart failure
with preserved left ventricular systolic function.
Methods: Forty-eight patients (25 men, 78±10 years) presenting pulmo-
nary edema with a left ventricular ejection fraction >45% were included. All
had a Doppler echocardiography at the time of intravenous loop diuretics ini-
tiation. Patients with severe valve disease or symptomatic coronary disease
were excluded.
Results: A history of heart failure, coronary disease, hypertension and dia-
betes was present in 62%, 42%, 64% and 33% of patients, respectively. On
admission, mean left ventricular ejection fraction was 61±9% and 79% of
patients had critical elevation in Doppler filling pressures. Associated factors
were renal failure (creatinine clearance <30 ml/min) in 33% patients, silent
myocardial ischemia (troponin I >0.5 ng/ml) in 31%, atrial fibrillation in 29%,
high systolic blood pressure (≥160 mmHg) in 27%, major sepsis in 25%,
severe hypoalbuminemia (≤2.5 g/dl) in 23%, and severe anemia (<10 g/dl) in
17%, respectively. Four patients had no aggravating factor, whereas 34 and
10 patients had 1–2 and 3–4 associated factors, respectively.
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Epidemiology, therapeutic and future of heart failure in Moroccan
women
Fatima Wadrahmane, Saloua Laaraibi
CHU Ibn Rochd Casablanca, Cardiologie, Casablanca, Maroc
Introducton: Heart failure affects nearly 5 million people in the United
States, and more than 50% of them are women. In Morocco like most devel-
oping countries there are no accurate statistics on the epidemiology of heart
failure in women 
Objectif: We report the experience of cardiology center. A retrospective
study from May 2009 to October 2012. 
The objective of our work is to analyze the epidemiological and therapeutic
and prognosis of heart failure in women
Materials and Methods: Of 1800 patients there were 630 women so 35%,
their mean age was 65±10 years. 47% of women were hypertensive, 38% dia-
betic, 21.6% sedentary, 20% postmenopausal and 12.3% obese. 353 patients
(56.05%) were in New York Heart Association class II, 180 (28.7%) in class
III and 18 (3.56%) in class IV. sixty eight  patients (10.9%) with atrial fibril-
lation. Heart rate on admission was greater than 80 beats per minute in
305 patients (48.5%). Only 15 patients had preserved systolic function. Heart
failure was ischemic in 47.42% cases, toxic in 4.76% cases, 10 patients had a
peripartum cardiomyopathy. About the treatment only 23.80% of women had
reached the target dose of beta blockers. After 1 year of follow up there 35%
were hospitalized at least 3 times, 4.2% of deaths (1.6% of cardiovascular
causes)..
Conclusion: Women tend to develop heart failure at an older age and with
better left ventricular systolic function compared with men. Women are more
likely than men to have hypertension and diabetes as underlying risk factors
for heart failure and are less likely to have coronary artery disease. 
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Heart failure in the presence of a normal left ventricular ejection frac-
tion: Algerian cohort.
Hocine Foudad (1), Ilyas Bouaguel (1), Abdelmoumene Mekarnia (2)
(1) Hôpital militaire Constantine, Service Cardiologie, Constantine, Algé-
rie – (2) HCA, Cardiologie, Alger, Algérie
Introduction and objectives: An increasing number of patients hospital-
ized for heart failure (HF) are found to have a normal left ventricular (LV)
ejection fraction (EF). The cause of HF in these patients is thought to be
related to LV diastolic dysfunction.
We conducted a multicenter study (military hospitals of Algiers and
Constantine) to define the clinical characteristics, hospital course, treatment,
and factors precipitating decompensation in patients hospitalized for heart
failure with a normal ejection fraction (HFNEF).
Methods: Patients hospitalized for heart failure (HF) during 2010-2012 at
the two medical centers in Algeria and found to have a left ventricular (LV)
ejection fraction of >50% were included in this study. 
Patient demographics, signs and symptoms of HF, coexisting and exacer-
bating cardiovascular and medical conditions, treatment, laboratory tests, and
hospital outcomes data were collected. 
Results: Of 296 patients, 81% were women, who were on average eight
years older than men (73.2 years vs. 65.3).
Co-morbid conditions and their prevalence were: hypertension, 84%;
increased LV mass, 92%; diabetes, 52%; and obesity, 67%. Before clinical
decompensation that precipitated hospitalization, 72% of patients had chronic
symptoms compatible with New York Heart Association functional classes II
to IV. Factors precipitating clinical decompensation were identified in 49% of
patients. In-hospital mortality was 4,05%.
Conclusions: Patients hospitalized for HFNEF are most often chronically
incapacitated elderly women with a history of hypertension and increased LV
mass. Reasons for clinical decompensation are identified in only one-half of
patients.
© Elsevier Masson SAS. All rights reserved.
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Electrocardiographic findings in primary systemic amyloidosis, senile
systemic amyloidosis and transthyretin-related amyloidosis.
Dionyssis Pongas (1), Claire-Marie Tissot (1), Dania Mohty (2), Diane
Bodez (3), Laurent Sabbah (4), Stéphane Rappeneau (1), Soulef Guen-
douz (3), Jean-Luc Dubois Randé (3), Luc Hittinger (3), Violaine Planté-
Bordeneuve (5), Nicolas Lellouche (3), Thibaud Damy (3)
(1) CHU Henri Mondor, UF insuffisance cardiaque, Créteil, France –
(2) CHU Limoges, Service de Cardiologie, Limoges, France – (3) CHU
Henri Mondor, Fédération de Cardiologie, Créteil, France – (4) CHU
Necker, Service de Cardiologie, Paris, France – (5) CHU Henri Mondor
– Réseau Amylose Mondorien, Service de Neurologie, Créteil, France
Objective: This study sought to determine the spectrum of electrocardio-
graphic (ECG) abnormalities found in patients with primary systemic amyloi-
dosis (AL), senile systemic amyloidosis (SSA) and Transthyretin-Related
Amyloidosis (TTR) and to evaluate the prognostic implications. 
Methods: Between 2010 and 2012, 103 patients treated in the University
Henri-Mondor Hospital with cardiac amyloidosis were included. 32 patients
with AL, 63 patients with TTR and 11 patients with SSA. ECG were analysed
regarding: rhythm, conduction, voltage, and ischaemic signs. The primary
endpoint was defined as death or heart transplantation.
Results: The mean age and men prevalence were respectively 62±15 and
64%. Atrial fibrillation was significantly more frequent (p=0.005) in the SSA
group (44%) compared to AL group (13%) and TTR group (7%). No significant
difference was found between the three groups when low voltage was defined
according to the Klein criteria or defined as a voltage inferior to 1 mV in all
precordial limbs. But when it was defined as a voltage <0, 5 mV in all limb
leads it was found significantly higher (p=0.006) in the AL population (36%)
compared to the TTR (8%) and SSA (25%) groups. LV hypertrophy was rare in
the three groups. No significant difference was found concerning conduction
disorders (p=0.064) and the presence of Q waves (61% AL, 51% TTR, 33%
SSA, p=0.51) or reduced R wave height (7% AL, 20% TTR, 0% SSA, p=0.14). 
Conclusion: Electrocardiographic abnormalities are frequent in amyloi-
dosis whatever the type.
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Midventricular Takotsubo cardiomyopathy: clinical characteristics
and prognosis.
Frédéric Moulin, Zied Frikha, Batric Popovic, Etienne Aliot, Olivier Huttin,
Michael Angioi
CHU Brabois, Département de Cardiologie, Vandoeuvre Les Nancy,
France
Background: Takotsubo cardiomyopathy was initially described as apical
ballooning with apical wall motion abnormalities. A group of patients pre-
senting with atypical appearence with mid-ventricular wall motion abnor-
mality was also described, but the incidence, the clinical characteristics and
the prognosis of this pattern have not yet been assessed.
Objectives: The aim of our study is to analyse the clinical profile, demo-
graphic characteristics and outcomes of patients with mid-ventricular Takot-
subo cardiomyopathy (TC).
Methods: A retrospective monocentric study enrolling fifty-six subsequent
patients hospitalised for TC, between January 2002 and January 2013. Only
patients with mid-ventricular form are included.
Results: The incidence of the midventricular form was 25% (14 patients).
The wall motion abnormalities in these patients were confirmed by both left
ventriculogram and cardiac magnetic resonance. The mean age was 65±10
years. Hypertension and dyslipidemia were the most common risk factors for
coronary heart disease (64.3% and 35.7% respectively). A history of cancer was
noted in 35.7%. A stressful event preceded presentation in 11 patients (78.6%).
Chest pain was the most common symptom (85.7%). Global T wave inversion
was the most frequent electrocardiographic changes (64.3%). The peak troponin
levels was 2.6±3.2 ng/ml. Mean left ventricular ejection fraction at initial pre-
sentation was moderetly impaired (45.5±9%). In-hospital mortality was 7% and
no other in-hospital complication was occurred. After a mean follow-up of
50±30 months, overall mortality, cardiovascular hospitalization and recurrence
were noted respectively in 15.4%, 46.2% and 7% of cases.
Conclusions: Our study demonstrated that midventricular takotsubo cardio-
myopathy is associated with significant  long term morbidity and mortality.
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Heart failure secondary to dilated cardiomyopathy: the correlation
between mechanical and electrical dyssynchrony: about 61 cases 
Sana Sioua, Sana Fennira, Saoussen Antit, Mohamed Habib Khaldi,
Sondos Kraiem
Hôpital Habib Thameur, Cardiologie, Tunis, Tunisie
Introduction: The existence of an abnormal electrical activation of the
myocardium is a common feature in the case of dilated cardiomyopathy. This
can lengthen the time of ventricular contraction and generate electro anoma-
lies affecting the contraction and the relaxation of the left ventricle.
Material and results: We conducted a prospective study of 61 patients with
heart failure secondary to dilated cardiomyopathy. This study aims to analyze
the correlation between electrocardiographic parameters and mechanical dyssyn-
chrony ( inter and intraventricular dyssynchrony).We found that 95% of patients
with complete left bundle branch block (BBGC) had whether inter or intraven-
tricular dyssynchrony. Among the patients with a BBGC, the number of those
with an interventricular dyssynchrony was equal to that of those with an intra-
ventricular dyssynchrony (23%). One hundred percent of our patients with a
QRS duration > 140 ms had whether an inter or an intraventricular dyssyn-
chrony.Inter or intraventricular asynchrony was also present in 45% of our
patients with a QRS duration ≤ 120ms. In this population, the prevalence of the
intraventricular dyssynchrony was higher than that of the interventricular one.
We found a statistically significant positive correlation between the QRS dura-
tion and the parameters of interventricular dyssynchrony in echocardiography
Doppler: Aortic pre-ejection delay (p<10-3) with an interval between the Aortic
and the Pulmonary pre-ejectionnel ( p<10-3).We also noted a statistically signif-
icant positive correlation  (p<10-3) between the QRS duration and the intraven-
tricular dyssynchrony measured by the Doppler echocardiography maximum
interval between electro-systolic delays.
Conclusion: The study demonstrates a significant association between
the prolonged QRS duration and the mechanical dyssynchrony. As a
matter of fact, nowadays , indicating a multisite pacemaker is based pri-
marily on the electrocardiographic criteria of dyssynchrony in the case of
an absence of an individualized reproducible criterion of the mechanical
dyssynchrony.
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New prognostic factors in heart failure with preserved ejection frac-
tion: the KaRen study
Erwan Donal (1), Lars Lund (2), Emmanuel Oger (1), Camilla Hage (2),
J-Claude Daubert (3), Cecilia Linde (2)
(1) CHU Rennes – Hôpital Pontchailloux, Rennes, France – (2) Karo-
linska Hospital, cardiology, Stokholm, Suède – (3) CHU Rennes, Départe-
ment de Cardiologie, Rennes, France
KaRen was a prospective multicentre study identifying predictors of out-
come in patients with Heart Failure and preserved Ejection Fraction (HFpEF),
with a special focus on electrical and mechanical dyssynchrony
Method: 539 patients were included following an acute HF presentation
accompanied with BNP> 100 pg/mL or NT-proBNP>300 pg/mL and LVEF
>45%. 438 patients were reassessed after 4 -8 weeks. ECG (18 variables) and
echo (117 variables) were analysed in core centres. Patients were followed
during a minimum of 18 months. The primary endpoint was time to all-cause
death or first HF hospitalisation. 
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